Alpha Tau Medical (DRTSW) Stock Analysis

What Alpha Tau Medical does

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Key metrics

ETFs linked to DRTSW

Broad-market and Healthcare sector ETFs an investor holding Alpha Tau Medical is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how DRTSW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Alpha Tau Medical?

Alpha Tau Medical trades under the ticker DRTSW on NASDAQ.

Which exchange is DRTSW listed on?

DRTSW is listed on NASDAQ.

What sector does Alpha Tau Medical operate in?

Alpha Tau Medical is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze DRTSW in a portfolio?

PortView shows DRTSW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.